11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

11 trials found

diseases per page:

Showing 1 to 10 of 11 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04768465 (ClinicalTrials.gov)	January 1, 2021	21/2/2021	Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis	Effectiveness and Safety of Tacrolimus Combined With Low-dose Prednisonefor Treatment of Myasthenia ...	Myasthenia Gravis	Drug: Pyridostigmine , Prednisone, Tacrolimus;Drug: Pyridostigmine , Tacrolimus	Da, Yuwei, M.D.	NULL	Recruiting	18 Years	N/A	All	160		China
2	ChiCTR1800017564	2018-09-08	2018-08-04	Optimal Timing of Thymectomy in Nonthymomatous Myasthenia Gravis Patients In China: A Follow-up Pros ...	Optimal Timing of Thymectomy in Nonthymomatous Myasthenia Gravis Patients In China: A Prospective St ...	Myasthenia Gravis	Experiment group versus Control group:Thymectomy plus oral prednisone, an immunosuppressant protocol ...	The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine	NULL	Pending	1	80	Both	Experiment group versus Control group:822;		China
3	ChiCTR-IPR-15006081	2014-07-18	2015-03-14	A prospective study of combined use of prednisoneand methotrexate for the treatment of myasthenia gr ...	A prospective study of combined use of prednisoneand methotrexate for the treatment of myasthenia gr ...	myasthenia gravis	prednisone group:prednisone;Prednisone + methotrexate:Prednisone + methotrexate;	Xuan Wu Hospital, Capital Medical University	NULL	Recruiting	18	80	Both	prednisone group:15;Prednisone + methotrexate:15;	Phase 4	NULL
4	NCT00995722 (ClinicalTrials.gov)	December 2011	14/10/2009	Efficacy of Prednisone In the Treatment of Ocular Myasthenia	Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study	Ocular Myasthenia Gravis	Drug: Prednisone;Drug: Placebo	Michael Benatar	University of Miami;University of Rochester	Terminated	18 Years	N/A	All	11	Phase 3	United States;Canada
5	NCT00987116 (ClinicalTrials.gov)	June 2009	29/9/2009	Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis	Comparison of Two Tapering Strategies of Prednisonein Patients With Generalised Myasthenia Gravis Tr ...	Myasthenia Gravis	Drug: Prednisone - Azathioprine	Assistance Publique - Hôpitaux de Paris	NULL	Completed	18 Years	80 Years	All	118	Phase 4	France
6	NCT00716066 (ClinicalTrials.gov)	June 2008	15/7/2008	Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases	High-Dose Immunosuppressive Therapy Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) + ...	Autoimmune Disease;Neurologic Autoimmune Disease;Autologous Transplant Autoimmune;Multiple Sclerosis ...	Biological: Anti-Thymocyte Globulin;Procedure: Autologous Hematopoietic Stem Cell Transplantation;Dr ...	Fred Hutchinson Cancer Center	NULL	Recruiting	N/A	71 Years	All	80	Phase 2	United States
7	NCT00294658 (ClinicalTrials.gov)	June 2006	21/2/2006	Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy	A Multi-Center, Single-Blind, Randomized Study Comparing Thymectomy to No Thymectomy in Non-Thymomat ...	Myasthenia Gravis	Procedure: thymectomy plus prednisone;Drug: prednisone alone	University of Alabama at Birmingham	National Institute of Neurological Disorders and Stroke (NINDS)	Completed	18 Years	65 Years	All	126	Phase 3	United States;Argentina;Australia;Brazil;Canada;Chile;Germany;Italy;Japan;Mexico;Netherlands;Poland; ...
8	EUCTR2005-000343-28-IT (EUCTR)	29/03/2006	15/03/2006	An optional continuation of double-blind treatment for subjects who have achieved good symptom contr ...	An optional continuation of double-blind treatment for subjects who have achieved good symptom contr ...	Myasthenia Gravis MedDRA version: 6.1;Level: PT;Classification code 10028417	Trade Name: cellcept INN or Proposed INN: Mycophenolic acid	ASPREVA PHARMACEUTICALS CORPORATION	NULL	Not Recruiting			Female: yes Male: yes	136		United Kingdom;Germany;Spain;Italy
9	EUCTR2005-000343-28-DE (EUCTR)	19/12/2005	10/05/2005	An optional continuation of double-blind treatment for subjects who have achieved good symptom contr ...	An optional continuation of double-blind treatment for subjects who have achieved good symptom contr ...	Myasthenia Gravis MedDRA version: 8.1;Level: PT;Classification code 10028417;Term: Myasthenia gravis ...	Trade Name: Cellcept 500 mg tablets Product Name: CellCept 500 mg tablets INN or Proposed INN: mycophe ...	Aspreva Pharmaceuticals Corporation	NULL	Not Recruiting			Female: yes Male: yes	136		Spain;Germany;Italy;United Kingdom
10	EUCTR2005-000343-28-GB (EUCTR)	05/09/2005	28/06/2005	An optional continuation of double-blind treatment for subjects who have achieved good symptom contr ...	An optional continuation of double-blind treatment for subjects who have achieved good symptom contr ...	Myasthenia Gravis MedDRA version: 7;Level: PT;Classification code 10028417	Product Name: CellCept 500 mg tablets INN or Proposed INN: mycophenolate mofetil	Aspreva Pharmaceutical Corporation	NULL	Not Recruiting			Female: yes Male: yes	136		Germany;United Kingdom;Spain;Italy

First Previous1 2Next Last